WO2012104087A2 - Cell culture device - Google Patents
Cell culture device Download PDFInfo
- Publication number
- WO2012104087A2 WO2012104087A2 PCT/EP2012/000467 EP2012000467W WO2012104087A2 WO 2012104087 A2 WO2012104087 A2 WO 2012104087A2 EP 2012000467 W EP2012000467 W EP 2012000467W WO 2012104087 A2 WO2012104087 A2 WO 2012104087A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- type
- chamber
- culture medium
- culturing
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 14
- 239000001963 growth medium Substances 0.000 claims abstract description 55
- 238000012258 culturing Methods 0.000 claims abstract description 42
- 230000011664 signaling Effects 0.000 claims abstract description 41
- 210000004027 cell Anatomy 0.000 claims description 176
- 239000012528 membrane Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 26
- 238000004458 analytical method Methods 0.000 claims description 20
- 230000008611 intercellular interaction Effects 0.000 claims description 7
- 210000000130 stem cell Anatomy 0.000 claims description 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 13
- 239000000758 substrate Substances 0.000 description 12
- 102100040247 Tumor necrosis factor Human genes 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 8
- 229960002986 dinoprostone Drugs 0.000 description 8
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 8
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 8
- 239000006143 cell culture medium Substances 0.000 description 7
- 239000007822 coupling agent Substances 0.000 description 7
- 210000002889 endothelial cell Anatomy 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 238000003501 co-culture Methods 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- -1 polydimethylsiloxane Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 101000817629 Homo sapiens Dymeclin Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229960000074 biopharmaceutical Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102100032814 ATP-dependent zinc metalloprotease YME1L1 Human genes 0.000 description 1
- 108010031480 Artificial Receptors Proteins 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000289669 Erinaceus europaeus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101001122137 Homo sapiens Olfactory receptor 11H1 Proteins 0.000 description 1
- 101001122134 Homo sapiens Olfactory receptor 11H2 Proteins 0.000 description 1
- 101000594464 Homo sapiens Olfactory receptor 2AP1 Proteins 0.000 description 1
- 101001122441 Homo sapiens Olfactory receptor 4A5 Proteins 0.000 description 1
- 101000721114 Homo sapiens Olfactory receptor 4D10 Proteins 0.000 description 1
- 101001138471 Homo sapiens Olfactory receptor 5H14 Proteins 0.000 description 1
- 101000992272 Homo sapiens Olfactory receptor 5M1 Proteins 0.000 description 1
- 101000598910 Homo sapiens Olfactory receptor 6J1 Proteins 0.000 description 1
- 101000598913 Homo sapiens Olfactory receptor 6K3 Proteins 0.000 description 1
- 101000968736 Homo sapiens Putative olfactory receptor 10D4 Proteins 0.000 description 1
- 101000594444 Homo sapiens Putative olfactory receptor 10J6 Proteins 0.000 description 1
- 101001137083 Homo sapiens Putative olfactory receptor 2W6 Proteins 0.000 description 1
- 101000990748 Homo sapiens Putative olfactory receptor 52L2 Proteins 0.000 description 1
- 101001086356 Homo sapiens Putative olfactory receptor 7A2 Proteins 0.000 description 1
- 101001121746 Homo sapiens Putative olfactory receptor 8G2 Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102100020816 Olfactory receptor 5H14 Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101800000795 Proadrenomedullin N-20 terminal peptide Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000002689 Toll-like receptor Human genes 0.000 description 1
- 108020000411 Toll-like receptor Proteins 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000003443 bladder cell Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000005033 mesothelial cell Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003668 pericyte Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 210000000229 preadipocyte Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 108091008597 receptor serine/threonine kinases Proteins 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/08—Chemical, biochemical or biological means, e.g. plasma jet, co-culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/06—Plates; Walls; Drawers; Multilayer plates
Definitions
- the present invention relates to a cell culture device for culturing together more than one types of cells.
- the present invention further relates to a method for culturing using such a device and a method for measuring intercellular interactions between more than one type of cells using such a device.
- EC endothelial cells
- SMC smooth muscle cells
- This publication describes coculture of EC and SMC in bilayer and conditioned media models.
- models were compared: SMCs cultured with ECs on the opposite side of the membrane in a bilayer coculture system that allows physical contact between ECs and SMCs (EC/SMC) and SMCs cultured in media continuously conditioned by ECs , without contact (conditioned media, CM).
- WO2007/106868 discloses a cell culture device having an ultrathin porous membrane.
- the device includes first and second chambers separated by at least one nanoscale membrane positioned between the first and second chambers, the at least one nanoscale membrane having an average thickness of less than about 100 nm, and having a plurality of pores extending between opposite sides thereof.
- an object of the present invention is to provide a cell culture device for culturing different types of interacting cells, which solve the above and/or other problems. Further objects will be apparent from the description below.
- a cell culture device for culturing together at least a first type of cells and a second, different type of cells, wherein the first type of cells secretes at least a first type of signaling molecules which interacts with the second type of cells and the second type of cells secretes at least a second type of signaling molecules which interacts with the first type of cells,
- the device comprises a first element having a first surface on which the first type of cells is present and a second element having a second surface on which the second type of cells is present and
- first surface and the second surface are separated only by a culture medium
- first element and the second element are detachable.
- the first surface and the second surface are separated only by the culture medium.
- the signaling molecules are allowed to reach the cells with which they interact, without moving through e.g. pores of a membrane.
- the lack of membrane or other types of barrier between the first type of cells and the second type of cells allows free traveling of any signaling molecules between the first type of cells and the second type of cells.
- the movement of the signaling molecules is not restricted and thus the signaling molecules can be of any size.
- the fact that the first and the second surface are separated results in that the first and the second types of cells do not come in physical contact with each other, preventing the first and the second types of cells from attaching to each other. This avoids the risk of the first and the second types of cells influencing the secretion of signaling molecules by the presence of the first (second) type of cells next to the second (first) type of cells.
- the first and the second surface are part of two detachable elements. This has an important advantage of allowing the two type of cells to be removed from the respective surface independently in separate environments after the culturing for any further measurements. In the case where the first and the second surface are not detachable, removing one type of cells by e.g. use of trypsin would usually result in the removal of the other type of cells, resulting in a mixture of two different types of cells. This is unsuitable when analysis of one specific type of cells is desired, e.g. when the amount of a certain molecule in the specific type of cells needs to be measured.
- the first type of cells may be induced to secrete the first type of signaling molecules before the second element is placed in its position for culturing. This is especially advantageous in the cases where the second type of cells need to be triggered by the first type of signaling molecules to secrete the second type of signaling molecules. It is advantageously ensured that the co-culturing is started in the presence of the first signaling molecules.
- the device may comprise further types of cells in addition to the first and the second types of cells.
- the first (second) type of cells may be present on the first (second) surface together with further different types of cells, i.e. two or more different types of cells may be present on the same surface.
- the cells may secrete further types of signaling molecules in addition to the first and the second types of signaling molecules.
- first (second) type of cells may secrete not only first (second) type of signaling molecules, but may also secrete further different types of signaling molecules. These further signaling molecules may be of the type that may or may not interact with the other cells.
- the first element is a chamber containing the liquid medium and the first surface is the bottom of the chamber.
- the first type of cells remains at the bottom of the first chamber by gravity. In most cases movement (e.g. by diffusion) of the first type of cells is small so that it will not reach the second type of cells and make a physical contact therewith. In the cases where it is desired to ensure no contact between the first and the second type of cells, the first type of cells at the bottom of the first chamber may be attached to the bottom.
- the second element may be suspended in the culture medium so that the second surface is in the liquid medium, i.e. under the surface of the culture medium.
- the second type of cells is preferably attached to the second surface of the second element. This is necessary e.g. when the second type of cells is present on the surface facing the bottom of the chamber. This is advantageous in that the first surface and the second surface face each other which makes it easy for the first (second) type of signaling molecules to reach the second (first) type of cells. In the cases where the second surface is facing up, i.e. where the second type of cells rests on a surface of the second element facing up, it is not necessary that the second type of cells is attached to the second surface of the second element.
- the suspended second element may take any suitable shape as long as it can be inserted in the chamber. Further, the suspending of the second element in the culture medium may be implemented in a number of ways.
- the suspended second element may e.g. be in a form of another chamber smaller than the chamber comprising the first type of cells at the bottom.
- the chamber to be inserted may have a rim that rests on the rim of the larger, receiving chamber.
- the suspended element may be a plate having a size that allows it to rest on the rim of the chamber. The plate may be provided with a protrusion protruding towards the bottom of the chamber, wherein the protrusion comprises the second surface to which the second type of cells is attached.
- the second surface may comprise a membrane.
- the membrane may be of any known type, e.g. PET, and may have pores of an average size of e.g. 0.1-10 pm, more typically 0.3-8 pm.
- the membrane may also be a membrane as disclosed in Fillinger et. Al, Journal of surgical research 67, p. 169 or WO2007/106868.
- the second element may in this case also contain a culture medium. This culture medium may be the same or different from the culture medium in the larger, receiving chamber.
- the suspended second element may also be implemented as a plurality of separate objects, e.g. in the form of bars or plates.
- the second type of cells may be attached to the surface of the bars or may rest on the plates.
- the case where the suspended element comprises a plurality of separate or separable surfaces has an advantage that each of the surfaces may be removed from the culture medium at different time points for analysis so that time-dependent results can be obtained.
- the cells cultured in the same culture medium in the same way but attached to different surfaces may also be subjected to different analysis methods.
- both the first and the second elements are suspended in the culture medium.
- the suspended element may take any suitable form, for example as described above in relation to the second element.
- the first type of cells and the second type of cells are preferably attached to the first surface and the second surface, respectively.
- more than two types of cells are cultured together. For example, all of said more than two types of cells are attached to different elements suspended in the culture medium. In other embodiments, one of said more than two types of cells is present at the bottom of the chamber containing cells and the rest of the cells are attached to different elements suspended in the culture medium.
- a further aspect of the present invention relates to a method of culturing together more than one type of cells.
- the method comprises the steps of: providing the device according to the present invention and culturing the first type of cells at the first surface and the second type of cells at the second surface.
- the step of providing the device may comprise the sub-steps of:
- the device according to the present invention is typically maintained in a steady position. This ensures that the cells are maintained in their respective positions.
- the device according to the present invention may be subjected to shaking during the culturing over part or the whole of the co-culturing process. This may facilitate the interaction between the different types of cells by inducing more movements of the signalling molecules.
- An yet further aspect of the present invention relates to a method for measuring intercellular interactions between cells, comprising the steps of: performing the method of co-culturing according to the present invention; detaching the first element and the second element; and subjecting the first type of cells and/or the second type of cells to an analysis.
- the analysis may measure the amounts of the first and/or the second signaling molecules in the first and/or the second type of cells.
- Any known analysis methods for cell may be used, including e.g. flow cytometry, enzyme- linked immunosorbent assay (ELISA), liquid chromatography-mass spectrometry (LCMS), gas chromatography-mass spectrometry (GCMS) and immunocytochemistry.
- the culture medium which acted as the transporting medium for the signaling molecules may also be subjected to this analysis. Accordingly, the method may further comprise the step of separating the culture medium from the first type of cells and the second type of cells and subjecting the culture medium to an analysis.
- the analysis of the culture medium may be performed without stopping the co-culturing in the device according to the present invention, by taking a sample of the culture medium while the co-culturing is still performed.
- the device used is a device according to the present invention where the second element is a chamber containing a culture medium inserted in the chamber of the first element and the second surface comprises a membrane. Sample may be taken from the culture medium in the chamber of the second element for analysis. This may be performed without stopping the co-culturing in the device according to the present invention. Accordingly, the method in these embodiments further comprises the step of subjecting the culture medium in the first chamber and/or the culture medium in the second chamber to an analysis while the method of co-culturing is performed
- the method for measuring intercellular interactions between cells involves use of a plurality of devices according to the present invention.
- Co-culturing of the cells is started in a plurality of devices according to the present invention at the same time.
- the co-culturing is stopped at different time points for different devices for analysis of the cells therein, so that time-dependent data can be obtained.
- co-culturing may be started for 10 devices according to the present invention.
- the rest of the group (8 devices) may go under the co- culturing for two hours, and two of them may be stopped for co-culturing and be subjected to an analysis.
- co-culturing may be stopped each time for two devices and they may be subjected to an analysis. Accordingly, there is provided a method comprising the steps of: providing a plurality of devices according to the present invention; co-culturing the cells in said plurality of devices according to the present invention and subjecting different sub-groups of the devices according to the present invention to an analysis at different predetermined times after the start of the co-culture.
- An yet further aspect of the present invention relates to use of the device according to the present invention for measuring intercellular interactions between cells.
- a system comprising a plurality of the device according the present invention.
- the first element of each of the devices is detachably connected to each other and/or the second elements are detachably connected to each other.
- a first substrate is provided comprising a plurality of holes each of which acts as the chamber for comprising the culture medium and a second substrate is provided comprising a plurality of protrusions each of which can be inserted to each of the holes of the first substrate.
- Each of the pairs consisting of the hole and the protrusion acts in the same way as the device of the present invention.
- each of the protrusions can be detached from the substrate. This facilitates (cells on) each of the protrusions to be subjected to analysis at different times. Similarly, if each of the holes can be detached from the substrate, subjecting (cells in) each of the holes to analysis at different times will become easier.
- the cells may be attached to the first and/or second surface in any known way.
- the ways to attach cells to a surface is well-known to the person skilled in the art. For example, collagen may be applied first and the cells may be subsequently applied. Another example is by providing a mechanical microstructure which is adapted so that cells can be attached thereto. Examples of such a mechanical microstructure of the surface include a textured microstructure and a porous microstructure having pores for accommodating the cells. Examples of ways of attaching cells to a surface is described e.g. in WO2007/106868. The description of WO2007/106868 is incorporated herein by reference with respect to the ways of attaching reagents to a membrane, which can be used in the present invention for attaching cells to the first and the second surfaces of the first and the second elements..
- Tethering of the reagent to the substrate includes covalently bonding the reagent to the lower surface of the substrate, ionically associating the reagent with the lower surface of the substrate, adsorbing the reagent onto the lower surface of the substrate, or the like. Such association can also include covalently or non-covalently attaching the reagent to another moiety (of a coupling agent), which in turn is covalently or non-covalently attached to the lower surface of the substrate.
- the surface may be first functionalized (i.e., primed) with a coupling agent that is attached to the surface thereof. This is achieved by providing a coupling agent precursor and then covalently or non-covalently binding the coupling agent precursor to the surface. Once the surface has been primed, the reagent is exposed to the primed surface under conditions effective to (i) covalently or non-covalently bind to the coupling agent or (ii) displace the coupling agent such that the reagent covalently or non-covalently binds directly to the membrane surface. The binding of the reagent to the substrate is carried out under conditions that are effective to allow one or more target-binding groups on the substrate to remain available for binding to a target reagent.
- the distance between the first surface and the second surface should be chosen so that the first type of signaling molecules reaches the second type of cells and/or the second type of signaling molecules reaches the first type of cells.
- the distance is dependent on the type of cells and the type of culture medium and can be optimized by the person skilled in the art.
- the distance may e.g. be 0.3-4 mm.
- the distance of 0.5-1.2mm may be more preferred.
- the distance between the two surfaces is referred as the distance between the two surfaces.
- the adjustment of the distance optimizes the communication between the cells while minimizing the risk of the first and the second types of cells to have a physical contact with each other by diffusion of the detached cells.
- the chamber used in the device according to the present invention can be formed by any suitable material and can have any desired configuration.
- the chamber can be in the form of a dish, a centrifuge tube, a cell culture tube, or the like.
- Exemplary materials for the chamber include, without limitation, glass, ceramic, polycarbonate, vinyl, polyvinyl chloride (PVC), polydimethylsiloxane (PDMS), acrylic, polypropylene, polyethylene, polyethyl sulfone (PES), and metal.
- Any combination of cells may be cultured in the culture device of the present invention.
- Animal cells are suitable, preferably mammalian cells. Particularly preferred are human cells.
- Other suitable cells include bacteria, cells of a fungus, yeast, algae and/or a plant.
- the cells may be genetically modified or altered cells.
- Preferred combinations of cells include combinations where at least one type of cells is human cells, such as human (primary) cells and bacteria cells. It is noted that human cells are commercially available.
- Preferred examples of the types of cells that can be cultured in the device of the present invention include human primary cells, such as adipocytes / preadipocytes, bladder cells, brain cells, cardiac cells, endothelial cells, epidermal cells, epithelial cells, eye cells, fibroblasts, granulocytes, hepatic cells, human mesothelial cells, intestine and colon cells, lung and pulmonary cells, lymph cells, lymphocytes, mononuclear cells, neural nerve cells, phagocytes, renal cells, reproductive cells, skeletal cells, smooth muscle cells and umbilical cells.
- human primary cells such as adipocytes / preadipocytes, bladder cells, brain cells, cardiac cells, endothelial cells, epidermal cells, epithelial cells, eye cells, fibroblasts, granulocytes, hepatic cells, human mesothelial cells, intestine and colon cells, lung and pulmonary cells, lymph cells, lymphocytes, mononuclear cells, neural nerve
- human stem cells such as mesenchymal stem cells, pericytes, CD34+ progenitor cells, CD133+ progenitor Cells, mononuclear cells and CD14+ Monocytes.
- Particularly suitable cells for culturing together in the device of the present invention include human aorta endothelial cells (HAOEC) and human peripheral blood mono-nuclear cells (PBMC).
- HEOEC human aorta endothelial cells
- PBMC human peripheral blood mono-nuclear cells
- one or more types of cultured cells can be collected using any suitable collection techniques.
- the first element and the second element are detached.
- the cells can be removed by use of e.g. trypsin.
- Cell signaling molecules that possesses a natural or synthetic receptor can be studied in a device of the present invention, for example cytokines or cytokine related signaling cascades.
- Cell signaling molecules worthy of study include, without limitation, members of the Wnt family, members of the hedgehog family, notch family members, interferon family members, molecules that recognize toll-like receptors such as PAMPs, lymphokines, chemokines, cytokines, hormones, interleukins, molecules recognizing receptors of the Immunoglobulin super family (e.g., IL-I), molecules recognizing receptor tyrosine kinase receptors (e.g., FGF, HGF, etc.), molecules recognizing receptor serine/threonine kinase receptors (e.g., TGF-[beta], BMP, BMP inhibitor, etc.), and molecules recognizing seven transmembrane helix receptors (e.g., fMLP, IL-8, etc.).
- Suitable culture media can be employed in the culture device of the present invention. Suitable culture media need to support the growth and differentiation of cells of various tissues and (optionally) any accessory cells included therein.
- the culture media can be supplemented with any growth factors, metabolites, etc.
- a cell culture medium for (mammalian) cells comprises salts, amino acids, vitamins, lipids, detergents, buffers, growth factors, hormones, cytokines, trace elements and carbohydrates.
- salts include magnesium salts, for example MgCI 2 .6H 2 0, MgS0 4 and MgS0 4 .7H 2 0 iron salts, for example FeS0 4 .7H 2 0, potassium salts, for example KH 2 P0 4 , KCI; sodium salts, for example NaH 2 P0 , Na 2 HPQ 4 and calcium salts, for example CaCI 2 .2H 2 0.
- amino acids are all 20 known proteinogenic amino acids, for example hystidine, glutamine, threonine, serine, methionine.
- vitamins include: ascorbate, biotin, choline.CI, myo-inositol, D-panthothenate, riboflavin.
- lipids include: fatty acids, for example linoleic acid and oleic acid; soy peptone and ethanol amine.
- detergents include Tween 80 and Pluronic F68.
- An example of a buffer is HEPES.
- growth factors/hormones/cytokines include IGF, hydrocortisone and (recombinant) insulin.
- trace elements are known to the person skilled in the art and include Zn, Mg and Se.
- carbohydrates include glucose, fructose, galactose and pyruvate.
- the pH, temperature, dissolved oxygen concentration and osmolarity of the cell culture medium are in principle not critical and depend on the type of cell chosen.
- the pH, temperature, dissolved oxygen concentration and osmolarity are chosen such that it is optimal for the growth and productivity of the cells.
- the person skilled in the art knows how to find the optimal pH, temperature, dissolved oxygen concentration and osmolarity for the perfusion culturing.
- the optimal pH is between 6.6 and 7.6, the optimal temperature between 30 and 39°C, the optimal osmolarity between 260 and 400mOsm/kg.
- the invention can in principle be used in any type of cell culture medium suitable for the culturing of (animal) cells.
- Guidelines for choosing a cell culture medium and cell culture conditions are well known and are for instance provided in Chapter 8 and 9 of Freshney, R. I. Culture of animal cells (a manual of basic
- Serum free media are preferred to media containing a serum source in the production of biopharmaceutical products as serum source media are frequently contaminated with viruses, present the risk of prionic infections, and can create a major obstacle in the downstream processing of the biopharmaceutical product (i. e. the further purification of the biopharmaceutical product from the cell culture medium).
- the cell culture medium is not only serum-free, but also mammalian source free. More preferably the cell culture medium is not only
- Figure 1 schematically illustrates an embodiment of the device according to the present invention
- Figure 2 schematically illustrates a further embodiment of the device according to the present invention
- Figure 3 schematically illustrates a further embodiment of the device according to the present invention.
- Figure 4 shows a graph showing the amounts of signaling molecules during the co-culturing method according to the present invention.
- Figure 5 shows a graph showing the amounts of signaling molecules during the co-culturing method according to a comparative example.
- a first element 100 in the form of a chamber comprises a bottom 101 and a side wall 102.
- the chamber 100 comprises a liquid culture medium 1 10.
- a first type of cells 10 secreting a first type of signaling molecules 1 1 rests on the bottom 101 (first surface) of the first chamber 100 by gravity.
- a second element 200 also in the form of a chamber is positioned within the first chamber 100. The second element 200 rests on the rim of the first element 100 by its rim.
- a second type of cells 20 secreting a first type of signaling molecules 21 is attached on the lower side (second surface) 201 of the bottom of the first chamber 200.
- the distance between the bottom 101 and the bottom 201 is such that the first type of signaling molecules 1 1 reaches the second type of cells 20 and the second type of signaling molecules 21 reaches the first type of cells 10.
- the first type of signaling molecules 11 may have an effect on the second type of cells 20 which increases or decreases the secretion of the second type of signaling molecules 21 by the second type of cells 20.
- the second type of signaling molecules 21 may have an effect on the first type of cells 10 which increases or decreases the secretion of the first type of signaling molecules 21 by the first type of cells 10.
- the second chamber 200 in figure 1 may also contain a culture medium. In the case that the bottom of the second chamber 200 is a membrane, the second type of cells can have a contact also with the culture medium in the second chamber.
- Figure 2 illustrates a further embodiment of the device according to the present invention.
- the first element 100 is identical to figure 1.
- a second element 200 is suspended in the culture medium 110 and hangs from a plate resting on the rim of the first element.
- the second element 200 is covered by a second type of cells attached thereto, which makes the whole surface of the second element 200 a second surface.
- the first and the second types of signaling molecules 1 1 and 21 work in the same was as described with respect to Figure 1.
- Figure 3 illustrates a further embodiment of the device according to the present invention.
- the device comprises a chamber filled with a culture medium, as in Figures 1 and 2.
- both the first element 100 and the second element 200 are suspended in the culture medium.
- the first and the second elements 100 and 200 in this embodiment are in the form of a bar, which is partly immersed in the culture medium.
- the portions immersed in the culture medium have cells attached thereto, i.e. the first element 100 has a first surface 101 to which first type of cells 10 are attached and the second element 200 has a first surface 201 to which first type of cells 20 are attached.
- the first and the second types of signaling molecules 1 1 and 21 work in the same was as described with respect to Figure 1.
- the first element 100 and the second element 200 are detachable from each other.
- the embodiment illustrated in Figure 3 may be modified such that the first type of cells are present at the bottom of the chamber and the second type of cells are attached to the two bars suspended in the culture medium as shown. It will be appreciated that the number of bars may be modified to be more than two.
- the inserting chamber had a rim which can rest on another cup when inserted.
- the inserting chamber had a membrane as the bottom.
- the membrane had pores with a diameter of 0.4pm and a pore density of 2*10 6 pores/cm 2 .
- the inserting chamber was placed upside down, i.e. the inserting chamber was placed so that the inside of the inserting chambers were facing downward.
- 50,000 cells/ml was prepared. 1 ml of the cell suspension was coated on the outer surface of the membrane coated with the collagen coating solution. The inserting chamber was left for 2 hours in a flow cabinet to allow the cells to firmly attach to the outer surface of the membrane via the collagen.
- a total of three inserting chambers having HAOEC attached on the outer surface of the membrane were made by the method described above, with 90% confluence.
- a receiving chamber (hereinafter sometimes referred as a receiving chamber) than the inserting chamber was provided.
- PBMC Primary human peripheral blood mono-nuclear cells
- RPMI culture medium
- FCS lipid poly sagaride
- TNF-a and PGE2 in the culture medium in the inserting chambers and the receiving chambers were measured respectively at time points 0, 4 and 24 hours after start of the co-culture.
- HAoEC were provided at the inner side of the inserting chamber.
- HAoEC and PBMC are separated by a membrane.
- TNF-a and PGE2 in the inserting chambers and the receiving chambers were measured respectively at time points 0, 4 and 24 hours after start of the co-culture.
- the comparative example shows that the amount of PGE2 in the receiving chamber or the inserting chamber remained extremely low while the amount of TNF in the receiving chamber was very high. This shows that PBMC in the receiving chamber released a large amount of TNF but it did not reach HAOEC in the inserting chamber. There was a very low passage of molecules from the receiving chamber to the inserting chamber through the membrane. Also, the amount of TNF- a in the receiving chamber significantly increased over time in the comparative example, whereas the increase was small in the example according to the invention. This shows that the release of PGE2 has an effect on the release of TNF-a by PBMC, which effect was not seen in the comparative example.
- communication in the comparative example may have been caused by the cells attached to the membrane blocking its pores for the signaling molecules to pass through.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a cell culture device for culturing together at least a first type of cells and a second, different type of cells, wherein the first type of cells secretes at least a first type of signaling molecules which interacts with the second type of cells and the second type of cells secretes at least a second type of signaling molecules which interacts with the first type of cells, wherein the device comprises a first element having a first surface on which the first type of cells is present and a second element having a second surface on which the second type of cells is present and wherein the first surface and the second surface are separated only by a culture medium and wherein the first element and the second element are detachable.
Description
CELL CULTURE DEVICE
The present invention relates to a cell culture device for culturing together more than one types of cells. The present invention further relates to a method for culturing using such a device and a method for measuring intercellular interactions between more than one type of cells using such a device.
Growth characteristics of cells are affected by other types of cells. One way of determining the behavior of cocultured cells is by cell culture devices comprising a membrane as described in the art. For example, coculture of interacting endothelial cells (EC) and smooth muscle cells (SMC) have been studied e.g. by Fillinger et. al, Journal of surgical research 67, p. 169. This publication describes coculture of EC and SMC in bilayer and conditioned media models. In this publication, models were compared: SMCs cultured with ECs on the opposite side of the membrane in a bilayer coculture system that allows physical contact between ECs and SMCs (EC/SMC) and SMCs cultured in media continuously conditioned by ECs , without contact (conditioned media, CM).
WO2007/106868 discloses a cell culture device having an ultrathin porous membrane. The device includes first and second chambers separated by at least one nanoscale membrane positioned between the first and second chambers, the at least one nanoscale membrane having an average thickness of less than about 100 nm, and having a plurality of pores extending between opposite sides thereof.
While these cell culture devices can be used for certain types of cells, suitable membranes having an appropriate pore size have to be chosen for each combination of types of cells. There is hence a need in the art for a cell culture device that is simple and which can be applied for diverse cells which secretes various signaling molecules.
Accordingly, an object of the present invention is to provide a cell culture device for culturing different types of interacting cells, which solve the above and/or other problems. Further objects will be apparent from the description below.
According to a first aspect of the present invention, a cell culture device is provided for culturing together at least a first type of cells and a second, different type of cells, wherein the first type of cells secretes at least a first type of signaling molecules which interacts with the second type of cells and the second type of cells secretes at least a second type of signaling molecules which interacts with the
first type of cells,
wherein the device comprises a first element having a first surface on which the first type of cells is present and a second element having a second surface on which the second type of cells is present and
wherein the first surface and the second surface are separated only by a culture medium and
wherein the first element and the second element are detachable.
According to the device of the present invention, the first surface and the second surface are separated only by the culture medium. This is herein meant that the first surface and the second surface are present in the same culture medium. The signaling molecules are allowed to reach the cells with which they interact, without moving through e.g. pores of a membrane. The lack of membrane or other types of barrier between the first type of cells and the second type of cells allows free traveling of any signaling molecules between the first type of cells and the second type of cells. The movement of the signaling molecules is not restricted and thus the signaling molecules can be of any size. The fact that the first and the second surface are separated results in that the first and the second types of cells do not come in physical contact with each other, preventing the first and the second types of cells from attaching to each other. This avoids the risk of the first and the second types of cells influencing the secretion of signaling molecules by the presence of the first (second) type of cells next to the second (first) type of cells.
The first and the second surface are part of two detachable elements. This has an important advantage of allowing the two type of cells to be removed from the respective surface independently in separate environments after the culturing for any further measurements. In the case where the first and the second surface are not detachable, removing one type of cells by e.g. use of trypsin would usually result in the removal of the other type of cells, resulting in a mixture of two different types of cells. This is unsuitable when analysis of one specific type of cells is desired, e.g. when the amount of a certain molecule in the specific type of cells needs to be measured.
Furthermore, this allows different types of cells to be subjected to different treatments or culturing before the first and the second elements are placed in their positions for culturing. For example, the first type of cells may be induced to secrete the first type of signaling molecules before the second element is placed in its position for culturing. This is especially advantageous in the cases where the second type of cells need to be triggered by the first type of signaling molecules to secrete the second type of signaling
molecules. It is advantageously ensured that the co-culturing is started in the presence of the first signaling molecules.
It is noted that the device may comprise further types of cells in addition to the first and the second types of cells. For example, the first (second) type of cells may be present on the first (second) surface together with further different types of cells, i.e. two or more different types of cells may be present on the same surface. It is further noted that the cells may secrete further types of signaling molecules in addition to the first and the second types of signaling molecules. For example, first (second) type of cells may secrete not only first (second) type of signaling molecules, but may also secrete further different types of signaling molecules. These further signaling molecules may be of the type that may or may not interact with the other cells.
It is further noted that the culturing together of two or more types of cells is sometimes referred herein as co-culturing.
In some embodiments, the first element is a chamber containing the liquid medium and the first surface is the bottom of the chamber. The first type of cells remains at the bottom of the first chamber by gravity. In most cases movement (e.g. by diffusion) of the first type of cells is small so that it will not reach the second type of cells and make a physical contact therewith. In the cases where it is desired to ensure no contact between the first and the second type of cells, the first type of cells at the bottom of the first chamber may be attached to the bottom.
The second element may be suspended in the culture medium so that the second surface is in the liquid medium, i.e. under the surface of the culture medium. The second type of cells is preferably attached to the second surface of the second element. This is necessary e.g. when the second type of cells is present on the surface facing the bottom of the chamber. This is advantageous in that the first surface and the second surface face each other which makes it easy for the first (second) type of signaling molecules to reach the second (first) type of cells. In the cases where the second surface is facing up, i.e. where the second type of cells rests on a surface of the second element facing up, it is not necessary that the second type of cells is attached to the second surface of the second element.
The suspended second element may take any suitable shape as long as it can be inserted in the chamber. Further, the suspending of the second element in the culture medium may be implemented in a number of ways. For example, the suspended second element may e.g. be in a form of another chamber smaller than the
chamber comprising the first type of cells at the bottom. The chamber to be inserted may have a rim that rests on the rim of the larger, receiving chamber. In another example, the suspended element may be a plate having a size that allows it to rest on the rim of the chamber. The plate may be provided with a protrusion protruding towards the bottom of the chamber, wherein the protrusion comprises the second surface to which the second type of cells is attached.
In embodiments where the second element is a chamber inserted in the chamber of the first element, the second surface may comprise a membrane. The membrane may be of any known type, e.g. PET, and may have pores of an average size of e.g. 0.1-10 pm, more typically 0.3-8 pm. The membrane may also be a membrane as disclosed in Fillinger et. Al, Journal of surgical research 67, p. 169 or WO2007/106868. The second element may in this case also contain a culture medium. This culture medium may be the same or different from the culture medium in the larger, receiving chamber.
The suspended second element may also be implemented as a plurality of separate objects, e.g. in the form of bars or plates. The second type of cells may be attached to the surface of the bars or may rest on the plates. The case where the suspended element comprises a plurality of separate or separable surfaces has an advantage that each of the surfaces may be removed from the culture medium at different time points for analysis so that time-dependent results can be obtained. The cells cultured in the same culture medium in the same way but attached to different surfaces may also be subjected to different analysis methods.
In further embodiments, both the first and the second elements are suspended in the culture medium. The suspended element may take any suitable form, for example as described above in relation to the second element. The first type of cells and the second type of cells are preferably attached to the first surface and the second surface, respectively.
It will be appreciated that only the surface on which the cells are attached needs to be in the culture medium and not the whole surface of the first and/or second element needs to be in the culture medium.
In further embodiments of the invention, more than two types of cells are cultured together. For example, all of said more than two types of cells are attached to different elements suspended in the culture medium. In other embodiments, one of said more than two types of cells is present at the bottom of the chamber containing cells and the rest of the cells are attached to different elements suspended in the
culture medium.
A further aspect of the present invention relates to a method of culturing together more than one type of cells. The method comprises the steps of: providing the device according to the present invention and culturing the first type of cells at the first surface and the second type of cells at the second surface. The step of providing the device may comprise the sub-steps of:
a) providing the first element in the form of a first chamber and the second element in the form of a second chamber insertable in the first chamber with a space between the bottom of the first chamber and the lower surface of the bottom of the second chamber,
b) providing the first type of cells at the bottom of the first chamber, c) providing the culture medium in the first chamber,
d) attaching the second type of cells at the lower surface of the bottom of the second chamber and
e) inserting the second chamber into the first chamber.
During the co-culturing, the device according to the present invention is typically maintained in a steady position. This ensures that the cells are maintained in their respective positions. In other cases, the device according to the present invention may be subjected to shaking during the culturing over part or the whole of the co-culturing process. This may facilitate the interaction between the different types of cells by inducing more movements of the signalling molecules.
An yet further aspect of the present invention relates to a method for measuring intercellular interactions between cells, comprising the steps of: performing the method of co-culturing according to the present invention; detaching the first element and the second element; and subjecting the first type of cells and/or the second type of cells to an analysis. The analysis may measure the amounts of the first and/or the second signaling molecules in the first and/or the second type of cells. Any known analysis methods for cell may be used, including e.g. flow cytometry, enzyme- linked immunosorbent assay (ELISA), liquid chromatography-mass spectrometry (LCMS), gas chromatography-mass spectrometry (GCMS) and immunocytochemistry. The culture medium which acted as the transporting medium for the signaling molecules may also be subjected to this analysis. Accordingly, the method may further comprise the step of separating the culture medium from the first type of cells and the second type of cells and subjecting the culture medium to an analysis.
Further, the analysis of the culture medium may be performed without
stopping the co-culturing in the device according to the present invention, by taking a sample of the culture medium while the co-culturing is still performed.
In some embodiments of the method of the present invention for measuring intercellular interactions, the device used is a device according to the present invention where the second element is a chamber containing a culture medium inserted in the chamber of the first element and the second surface comprises a membrane. Sample may be taken from the culture medium in the chamber of the second element for analysis. This may be performed without stopping the co-culturing in the device according to the present invention. Accordingly, the method in these embodiments further comprises the step of subjecting the culture medium in the first chamber and/or the culture medium in the second chamber to an analysis while the method of co-culturing is performed
In a further embodiment, the method for measuring intercellular interactions between cells involves use of a plurality of devices according to the present invention. Co-culturing of the cells is started in a plurality of devices according to the present invention at the same time. The co-culturing is stopped at different time points for different devices for analysis of the cells therein, so that time-dependent data can be obtained. For example, co-culturing may be started for 10 devices according to the present invention. At the start of the co-culture (time=0), two of the devices may be subjected to an analysis. The rest of the group (8 devices) may go under the co- culturing for two hours, and two of them may be stopped for co-culturing and be subjected to an analysis. Similarly, after 6, 12 and 24 hours after the start of the co- culture, co-culturing may be stopped each time for two devices and they may be subjected to an analysis. Accordingly, there is provided a method comprising the steps of: providing a plurality of devices according to the present invention; co-culturing the cells in said plurality of devices according to the present invention and subjecting different sub-groups of the devices according to the present invention to an analysis at different predetermined times after the start of the co-culture.
An yet further aspect of the present invention relates to use of the device according to the present invention for measuring intercellular interactions between cells.
According to a further aspect of the invention, a system is provided comprising a plurality of the device according the present invention. Preferably, the first element of each of the devices is detachably connected to each other and/or the second elements are detachably connected to each other. In one embodiment of this
system, a first substrate is provided comprising a plurality of holes each of which acts as the chamber for comprising the culture medium and a second substrate is provided comprising a plurality of protrusions each of which can be inserted to each of the holes of the first substrate. Each of the pairs consisting of the hole and the protrusion acts in the same way as the device of the present invention. Preferably, each of the protrusions can be detached from the substrate. This facilitates (cells on) each of the protrusions to be subjected to analysis at different times. Similarly, if each of the holes can be detached from the substrate, subjecting (cells in) each of the holes to analysis at different times will become easier.
The cells may be attached to the first and/or second surface in any known way. The ways to attach cells to a surface is well-known to the person skilled in the art. For example, collagen may be applied first and the cells may be subsequently applied. Another example is by providing a mechanical microstructure which is adapted so that cells can be attached thereto. Examples of such a mechanical microstructure of the surface include a textured microstructure and a porous microstructure having pores for accommodating the cells. Examples of ways of attaching cells to a surface is described e.g. in WO2007/106868. The description of WO2007/106868 is incorporated herein by reference with respect to the ways of attaching reagents to a membrane, which can be used in the present invention for attaching cells to the first and the second surfaces of the first and the second elements..
Tethering of the reagent to the substrate includes covalently bonding the reagent to the lower surface of the substrate, ionically associating the reagent with the lower surface of the substrate, adsorbing the reagent onto the lower surface of the substrate, or the like. Such association can also include covalently or non-covalently attaching the reagent to another moiety (of a coupling agent), which in turn is covalently or non-covalently attached to the lower surface of the substrate.
The surface may be first functionalized (i.e., primed) with a coupling agent that is attached to the surface thereof. This is achieved by providing a coupling agent precursor and then covalently or non-covalently binding the coupling agent precursor to the surface. Once the surface has been primed, the reagent is exposed to the primed surface under conditions effective to (i) covalently or non-covalently bind to the coupling agent or (ii) displace the coupling agent such that the reagent covalently or non-covalently binds directly to the membrane surface. The binding of the reagent to the substrate is carried out under conditions that are effective to allow one or more target-binding groups on the substrate to remain available for binding to a target
reagent. Many of these materials and coupling agents are described in U.S. Patent Application Serial No. 10/082,634 to Chan et al, and U.S. Patent Application Serial No. 10/282,274 to Miller et al., each of which is hereby incorporated by reference in its entirety.
The distance between the first surface and the second surface should be chosen so that the first type of signaling molecules reaches the second type of cells and/or the second type of signaling molecules reaches the first type of cells. The distance is dependent on the type of cells and the type of culture medium and can be optimized by the person skilled in the art. The distance may e.g. be 0.3-4 mm. The distance of 0.5-1.2mm may be more preferred. In the cases where the distance between the first and the second surfaces vary, the smallest distance between the two surfaces is referred as the distance between the two surfaces. The adjustment of the distance optimizes the communication between the cells while minimizing the risk of the first and the second types of cells to have a physical contact with each other by diffusion of the detached cells.
The chamber used in the device according to the present invention can be formed by any suitable material and can have any desired configuration. For example, the chamber can be in the form of a dish, a centrifuge tube, a cell culture tube, or the like. Exemplary materials for the chamber include, without limitation, glass, ceramic, polycarbonate, vinyl, polyvinyl chloride (PVC), polydimethylsiloxane (PDMS), acrylic, polypropylene, polyethylene, polyethyl sulfone (PES), and metal.
Any combination of cells may be cultured in the culture device of the present invention. Animal cells are suitable, preferably mammalian cells. Particularly preferred are human cells. Other suitable cells include bacteria, cells of a fungus, yeast, algae and/or a plant. The cells may be genetically modified or altered cells.
Preferred combinations of cells include combinations where at least one type of cells is human cells, such as human (primary) cells and bacteria cells. It is noted that human cells are commercially available.
Preferred examples of the types of cells that can be cultured in the device of the present invention include human primary cells, such as adipocytes / preadipocytes, bladder cells, brain cells, cardiac cells, endothelial cells, epidermal cells, epithelial cells, eye cells, fibroblasts, granulocytes, hepatic cells, human mesothelial cells, intestine and colon cells, lung and pulmonary cells, lymph cells, lymphocytes, mononuclear cells, neural nerve cells, phagocytes, renal cells, reproductive cells, skeletal cells, smooth muscle cells and umbilical cells. Further
preferred examples of the types of cells that can be cultured in the device of the present invention include human stem cells such as mesenchymal stem cells, pericytes, CD34+ progenitor cells, CD133+ progenitor Cells, mononuclear cells and CD14+ Monocytes.
Particularly suitable cells for culturing together in the device of the present invention include human aorta endothelial cells (HAOEC) and human peripheral blood mono-nuclear cells (PBMC).
Once the co-culturing of cells has achieved its purpose, one or more types of cultured cells can be collected using any suitable collection techniques. For the purpose of separately analyzing the first type of cells and the second type of cells, the first element and the second element are detached. In the cases where the cells are attached to the surface, the cells can be removed by use of e.g. trypsin.
Any signaling molecule that possesses a natural or synthetic receptor can be studied in a device of the present invention, for example cytokines or cytokine related signaling cascades. Cell signaling molecules worthy of study include, without limitation, members of the Wnt family, members of the hedgehog family, notch family members, interferon family members, molecules that recognize toll-like receptors such as PAMPs, lymphokines, chemokines, cytokines, hormones, interleukins, molecules recognizing receptors of the Immunoglobulin super family (e.g., IL-I), molecules recognizing receptor tyrosine kinase receptors (e.g., FGF, HGF, etc.), molecules recognizing receptor serine/threonine kinase receptors (e.g., TGF-[beta], BMP, BMP inhibitor, etc.), and molecules recognizing seven transmembrane helix receptors (e.g., fMLP, IL-8, etc.). A particularly useful example include TNF-a (Tumor necrosis factor a) and PGE2 (prostaglandin E2).
Any suitable culture media can be employed in the culture device of the present invention. Suitable culture media need to support the growth and differentiation of cells of various tissues and (optionally) any accessory cells included therein. The culture media can be supplemented with any growth factors, metabolites, etc.
Generally, a cell culture medium for (mammalian) cells comprises salts, amino acids, vitamins, lipids, detergents, buffers, growth factors, hormones, cytokines, trace elements and carbohydrates. Examples of salts include magnesium salts, for example MgCI2.6H20, MgS04 and MgS04.7H20 iron salts, for example FeS04.7H20, potassium salts, for example KH2P04, KCI; sodium salts, for example NaH2P0 , Na2HPQ4 and calcium salts, for example CaCI2.2H20. Examples of amino
acids are all 20 known proteinogenic amino acids, for example hystidine, glutamine, threonine, serine, methionine. Examples of vitamins include: ascorbate, biotin, choline.CI, myo-inositol, D-panthothenate, riboflavin. Examples of lipids include: fatty acids, for example linoleic acid and oleic acid; soy peptone and ethanol amine.
Examples of detergents include Tween 80 and Pluronic F68. An example of a buffer is HEPES. Examples of growth factors/hormones/cytokines include IGF, hydrocortisone and (recombinant) insulin. Examples of trace elements are known to the person skilled in the art and include Zn, Mg and Se. Examples of carbohydrates include glucose, fructose, galactose and pyruvate.
The pH, temperature, dissolved oxygen concentration and osmolarity of the cell culture medium are in principle not critical and depend on the type of cell chosen. Preferably, the pH, temperature, dissolved oxygen concentration and osmolarity are chosen such that it is optimal for the growth and productivity of the cells. The person skilled in the art knows how to find the optimal pH, temperature, dissolved oxygen concentration and osmolarity for the perfusion culturing. Usually, the optimal pH is between 6.6 and 7.6, the optimal temperature between 30 and 39°C, the optimal osmolarity between 260 and 400mOsm/kg.
The invention can in principle be used in any type of cell culture medium suitable for the culturing of (animal) cells. Guidelines for choosing a cell culture medium and cell culture conditions are well known and are for instance provided in Chapter 8 and 9 of Freshney, R. I. Culture of animal cells (a manual of basic
techniques), 4th edition 2000, Wiley-Liss and in Doyle, A. , Griffiths, J. B., Newell, D. G. Cell & Tissue culture: Laboratory Procedures 1993, John Wiley & Sons.
Serum free media are preferred to media containing a serum source in the production of biopharmaceutical products as serum source media are frequently contaminated with viruses, present the risk of prionic infections, and can create a major obstacle in the downstream processing of the biopharmaceutical product (i. e. the further purification of the biopharmaceutical product from the cell culture medium).
Since compounds from a mammalian source also present an infection risk, preferably, the cell culture medium is not only serum-free, but also mammalian source free. More preferably the cell culture medium is not only
mammalian source-free, but also animal source free.
Although the invention has been described in detail for purposes of illustration, it is understood that such detail is solely for that purpose, and variations can be made therein by those skilled in the art without departing from the spirit and scope
of the invention as defined in the claims.
It is further noted that the invention relates to all possible
combinations of features described herein, especially in the claims. The invention is illustrated hereinbelow referring to the figures in which:
Figure 1 schematically illustrates an embodiment of the device according to the present invention;
Figure 2 schematically illustrates a further embodiment of the device according to the present invention;
Figure 3 schematically illustrates a further embodiment of the device according to the present invention;
Figure 4 shows a graph showing the amounts of signaling molecules during the co-culturing method according to the present invention and
Figure 5 shows a graph showing the amounts of signaling molecules during the co-culturing method according to a comparative example.
Referring to figure 1 , the cell culture device according to the present invention is illustrated. A first element 100 in the form of a chamber comprises a bottom 101 and a side wall 102. The chamber 100 comprises a liquid culture medium 1 10. A first type of cells 10 secreting a first type of signaling molecules 1 1 rests on the bottom 101 (first surface) of the first chamber 100 by gravity. A second element 200 also in the form of a chamber is positioned within the first chamber 100. The second element 200 rests on the rim of the first element 100 by its rim. A second type of cells 20 secreting a first type of signaling molecules 21 is attached on the lower side (second surface) 201 of the bottom of the first chamber 200. The distance between the bottom 101 and the bottom 201 is such that the first type of signaling molecules 1 1 reaches the second type of cells 20 and the second type of signaling molecules 21 reaches the first type of cells 10. The first type of signaling molecules 11 may have an effect on the second type of cells 20 which increases or decreases the secretion of the second type of signaling molecules 21 by the second type of cells 20. The second type of signaling molecules 21 may have an effect on the first type of cells 10 which increases or decreases the secretion of the first type of signaling molecules 21 by the first type of cells 10.
The second chamber 200 in figure 1 may also contain a culture medium. In the case that the bottom of the second chamber 200 is a membrane, the second type of cells can have a contact also with the culture medium in the second chamber.
Figure 2 illustrates a further embodiment of the device according to the present invention. The first element 100 is identical to figure 1. A second element 200 is suspended in the culture medium 110 and hangs from a plate resting on the rim of the first element. The second element 200 is covered by a second type of cells attached thereto, which makes the whole surface of the second element 200 a second surface. The first and the second types of signaling molecules 1 1 and 21 work in the same was as described with respect to Figure 1.
Figure 3 illustrates a further embodiment of the device according to the present invention. The device comprises a chamber filled with a culture medium, as in Figures 1 and 2. However, in this embodiment, both the first element 100 and the second element 200 are suspended in the culture medium. The first and the second elements 100 and 200 in this embodiment are in the form of a bar, which is partly immersed in the culture medium. The portions immersed in the culture medium have cells attached thereto, i.e. the first element 100 has a first surface 101 to which first type of cells 10 are attached and the second element 200 has a first surface 201 to which first type of cells 20 are attached. The first and the second types of signaling molecules 1 1 and 21 work in the same was as described with respect to Figure 1. The first element 100 and the second element 200 are detachable from each other.
Many modifications of the device of the present invention are possible. For example, the embodiment illustrated in Figure 3 may be modified such that the first type of cells are present at the bottom of the chamber and the second type of cells are attached to the two bars suspended in the culture medium as shown. It will be appreciated that the number of bars may be modified to be more than two.
Examples
Example 1
The device according to the embodiment the present invention schematically illustrated in Figure 1 was used.
Fixing cells on the inserting chamber
A cylindrical cup for inserting in another cup was provided
(hereinafter sometimes referred as an inserting chamber). The inserting chamber had a rim which can rest on another cup when inserted. The inserting chamber had a membrane as the bottom. The membrane had pores with a diameter of 0.4pm and a pore density of 2*106pores/cm2. (ThinCert, Greiner Bio-One)
The inserting chamber was placed upside down, i.e. the inserting chamber was placed so that the inside of the inserting chambers were facing downward.
500 μΙ_ of collagen coating solution (Cell Applications Inc) was placed on the outer surface of the membrane of the inserting chamber using a pipet. The entire outer surface of the membrane was covered and allowed to stand for 4 hours at room temperature in a flow cabinet. Subsequently, the collagen coating solution was washed away from the membrane with PBS. The inserting chambers were stored at 4 °C until use.
A suspension of human aorta endothelial cells (HAOEC) containing
50,000 cells/ml was prepared. 1 ml of the cell suspension was coated on the outer surface of the membrane coated with the collagen coating solution. The inserting chamber was left for 2 hours in a flow cabinet to allow the cells to firmly attach to the outer surface of the membrane via the collagen.
A total of three inserting chambers having HAOEC attached on the outer surface of the membrane were made by the method described above, with 90% confluence.
Providing cells in the receiving chamber
Three chambers each having a larger diameter and depth
(hereinafter sometimes referred as a receiving chamber) than the inserting chamber was provided.
Primary human peripheral blood mono-nuclear cells (PBMC) were seeded at the bottom of the receiving chamber comprising a culture medium RPMI (Sigma) with 10% FCS at 1 ,000,000ells/chamber. The PBMC were stimulated with 10 pg/ml lipid poly sagaride (LPS) from Sigma. After 1 hour the culture medium was replaced by a culture medium without LPS and PBMC were left to secrete TNF-a for another 6 hours. Culturing of cells
The inserting chambers with HAOEC were inserted in the receiving chambers with PBMC. The distance between the surface with HAOEC and the surface with PBMC was 0.7 mm. 3 ml of a culture medium was added to each of the receiving chambers and 1 ml of the same culture medium was added to each of the inserting chambers. The three pairs of chambers were placed in an incubator at a temperature of 37°C and having an atmosphere of 5% C02.
The amounts of TNF-a and PGE2 in the culture medium in the inserting chambers and the receiving chambers were measured respectively at time points 0, 4 and 24 hours after start of the co-culture.
Results are shown in Figure 4.
Comparative example 1
The same device according to the embodiment of the present invention schematically illustrated in Figure 1 was used, except that the HAoEC were provided at the inner side of the inserting chamber. In this construction, HAoEC and PBMC are separated by a membrane.
The amounts of TNF-a and PGE2 in the inserting chambers and the receiving chambers were measured respectively at time points 0, 4 and 24 hours after start of the co-culture.
Results are shown in Figure 5.
It can be seen that, in the device according to the example (Table 1 ), the amount of TNF-a in the receiving chamber increased after the start of co-culturing, indicating that PBMC in the receiving chamber was releasing TNF-a. The amount of PGE2 in the receiving chamber increased with time. This indicates that HAOEC released PGE2, stimulated by TNF-a. It is therefore concluded that a good
communication was established between HAOEC and PBMC in the receiving chamber in the device according to the present invention.
In comparison, the comparative example (Table 2) shows that the amount of PGE2 in the receiving chamber or the inserting chamber remained extremely low while the amount of TNF in the receiving chamber was very high. This shows that PBMC in the receiving chamber released a large amount of TNF but it did not reach HAOEC in the inserting chamber. There was a very low passage of molecules from the receiving chamber to the inserting chamber through the membrane. Also, the amount of TNF- a in the receiving chamber significantly increased over time
in the comparative example, whereas the increase was small in the example according to the invention. This shows that the release of PGE2 has an effect on the release of TNF-a by PBMC, which effect was not seen in the comparative example.
Although not wishing to be bound by theory, the lack of
communication in the comparative example may have been caused by the cells attached to the membrane blocking its pores for the signaling molecules to pass through.
Claims
1. A cell culture device for culturing together at least a first type of cells and a second, different type of cells, wherein the first type of cells secretes at least a first type of signaling molecules which interacts with the second type of cells and the second type of cells secretes at least a second type of signaling molecules which interacts with the first type of cells,
wherein the device comprises a first element having a first surface on which the first type of cells is present and a second element having a second surface on which the second type of cells is present and
wherein the first surface and the second surface are separated only by a culture medium and
wherein the first element and the second element are detachable.
2. The device according to claim 1 , wherein the first element is a chamber
containing the culture medium and the first surface is the bottom of the chamber.
3. The device according to claim 2, wherein the second element is suspended in the culture medium in the chamber.
4. The device according to claim 2 or 3, wherein at least part of the second
surface faces toward the first surface and the second type of cells is attached to the second surface.
5. The device according to claim 2, 3 or 4, wherein the second element is a
chamber which is inserted in the chamber of the first element.
6. The device according to claim 5, wherein the chamber of the second element contains a culture medium.
7. The device according to claim 5 or 6, wherein the chamber of the second
element comprises a membrane at its bottom and the second surface is the lower surface of the membrane.
8. The device according to claim 1 , wherein the first element and the second element are both suspended in a culture medium.
9. The device according to claim 8, wherein the first type of cells is attached to the first surface and/or the second type of cells is attached to the second surface.
10. The device according to any one of claims 1-9, wherein the first type of cells and/or the second type of cells is human primary cells or human stem cells. A method of culturing together at least a first type of cells and a second type of cells, comprising the steps of:
providing the device according to any one of claims 1-10 and
- culturing the first type of cells at the first surface and the second type of cells at the second surface.
The method according to claim 1 1 , wherein the step of providing the device comprises the sub-steps of:
a) providing the first element in the form of a first chamber and the second element in the form of a second chamber insertable in the first chamber with a space between the bottom of the first chamber and the lower surface of the bottom of the second chamber,
b) providing a first type of cells at the bottom of the first chamber,
c) providing a culture medium in the first chamber,
d) attaching the second type of cells at the lower surface of the bottom of the second chamber and
e) inserting the second chamber into the first chamber.
A method of measuring intercellular interactions between cells, comprising the steps of:
- performing the method of co-culturing according to claim 1 1 or 12;
- detaching the first element and the second element; and
- subjecting the first type of cells and/or the second type of cells to an
analysis.
The method according to claim 13, wherein the device according to claim 6 is used and the method further comprises the step of subjecting the culture medium in the first chamber and/or the culture medium in the second chamber to an analysis while the method of co-culturing is performed.
Use of the device according to any one of claims 1-10 for measuring intercellular interactions between different kinds of cells.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438728P | 2011-02-02 | 2011-02-02 | |
| EP11000811 | 2011-02-02 | ||
| EP11000811.7 | 2011-02-02 | ||
| US61/438,728 | 2011-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012104087A2 true WO2012104087A2 (en) | 2012-08-09 |
| WO2012104087A3 WO2012104087A3 (en) | 2012-12-20 |
Family
ID=44261757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2012/000467 WO2012104087A2 (en) | 2011-02-02 | 2012-02-02 | Cell culture device |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012104087A2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007106868A2 (en) | 2006-03-14 | 2007-09-20 | University Of Rochester | Cell culture devices having ultrathin porous membrane and uses thereof |
| US8263402B1 (en) | 1998-10-19 | 2012-09-11 | Cornell Research Foundation, Inc. | Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5759851A (en) * | 1995-08-03 | 1998-06-02 | Corning Incorporated | Reversible membrane insert for growing tissue cultures |
| AU2003268200A1 (en) * | 2002-08-27 | 2004-03-19 | Vanderbilt University | Bioreactors with substance injection capacity |
| WO2007021919A1 (en) * | 2005-08-12 | 2007-02-22 | Clemson University | Co-culture bioreactor system |
| KR100718158B1 (en) * | 2006-04-21 | 2007-05-14 | 삼성전자주식회사 | Cell coculture device |
| CN102428172A (en) * | 2009-03-20 | 2012-04-25 | 新加坡科技研究局 | Culture of pluripotent and multipotent cells on microcarriers |
-
2012
- 2012-02-02 WO PCT/EP2012/000467 patent/WO2012104087A2/en active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263402B1 (en) | 1998-10-19 | 2012-09-11 | Cornell Research Foundation, Inc. | Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
| WO2007106868A2 (en) | 2006-03-14 | 2007-09-20 | University Of Rochester | Cell culture devices having ultrathin porous membrane and uses thereof |
Non-Patent Citations (3)
| Title |
|---|
| DOYLE, A.; GRIFFITHS, J. B.; NEWELL, D. G.: "Cell & Tissue culture: Laboratory Procedures", 1993, JOHN WILEY & SONS |
| FILLINGER, JOURNAL OF SURGICAL RESEARCH, vol. 67, pages 169 |
| FRESHNEY, R. I.: "Culture of animal cells", 2000, WILEY-LISS |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012104087A3 (en) | 2012-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101983486B1 (en) | Method, apparatus and kit for mass cell culture using polyimide porous membrane | |
| Ozawa et al. | Alginate gel microwell arrays using electrodeposition for three-dimensional cell culture | |
| US10982186B2 (en) | Cell culturing method and kit | |
| Wang et al. | In vitro generation of colonic epithelium from primary cells guided by microstructures | |
| JP7451427B2 (en) | Formation of an array of planar intestinal crypts with stem cell/proliferating cell compartments and differentiated cell zones | |
| WO2013116449A1 (en) | Automatic continuous perfusion cell culture microplate consumables | |
| JP6492106B2 (en) | Method for preparing cells for 3D tissue culture | |
| KR101845588B1 (en) | In vitro Expansion of Erythroid Cells | |
| Lee et al. | Membrane-bottomed microwell array added to Transwell insert to facilitate non-contact co-culture of spermatogonial stem cell and STO feeder cell | |
| CN104812911B (en) | Method for evaluating effects of cytokines on metabolic ability of cytochrome P450 and method for screening drugs | |
| US20100297675A1 (en) | Substrate and method for culturing breast cells | |
| JP2024112981A (en) | In vitro cell culture mucus system | |
| US8993322B2 (en) | Methods and kits for cell release | |
| JP6950887B2 (en) | Extracorporeal artificial liver and equipment for extracorporeal artificial liver or hepatocyte culture | |
| US20220290083A1 (en) | Cell culturing method using small-piece porous membrane | |
| WO2012104087A2 (en) | Cell culture device | |
| WO2018021357A1 (en) | Method to suppress stem cell differentiation, method to prepare stem cells, and method to induce differentiation of stem cells | |
| Yang et al. | Collagen Hydrogel Tube Microbioreactors for Cell and Tissue Manufacturing | |
| Paniushkina et al. | Three-dimensional cell models for extracellular vesicles production, isolation, and characterization | |
| KR102437810B1 (en) | Cell preparation method, cell cultivation device, and kit | |
| CN107208126A (en) | Methods of Isolating, Removing, and Analyzing Cells | |
| KR102281171B1 (en) | Cell preparation method, cell culture device and kit | |
| Xue et al. | PARACRINE SIGNALING FROM HUMAN KIDNEY EPITHELIAL CELLS PROMOTES KIDNEY SPECIFICITY OF ENDOTHELIAL CELLS | |
| JP5307489B2 (en) | Method for producing three-dimensional cell structure | |
| Yoshimoto et al. | Cyclic mechanical stretching stimuli promotes angiocrine signals during in vitro liver bud formation from human pluripotent stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12703695 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A, DATED 16.01.2014) |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12703695 Country of ref document: EP Kind code of ref document: A2 |